Detalhe da pesquisa
1.
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
J Neurol Neurosurg Psychiatry
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569872
2.
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina.
Neurol Sci
; 45(2): 379-389, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38159147
3.
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting.
Mult Scler
; 29(10): 1240-1249, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491849
4.
Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina.
Neurol Sci
; 44(1): 281-286, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36166174
5.
Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis: Multicenter study in Argentina.
Mult Scler
; 27(4): 579-584, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32484381
6.
Risk of secondary progressive multiple sclerosis: A longitudinal study.
Mult Scler
; 26(1): 79-90, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31397221
7.
Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Neurol Sci
; 41(11): 3329-3335, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32840711
8.
Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM).
Neurol Sci
; 41(6): 1513-1519, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31960250
9.
Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 88(3): 196-203, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27683916
10.
Contribution of different relapse phenotypes to disability in multiple sclerosis.
Mult Scler
; 23(2): 266-276, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27055805
11.
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 87(12): 1343-1349, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27810919
12.
Correction to: Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Neurol Sci
; 42(12): 5441, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34557969
13.
Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.
Ann Neurol
; 76(6): 880-90, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25283272
14.
Predictors and dynamics of postpartum relapses in women with multiple sclerosis.
Mult Scler
; 20(6): 739-46, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24107309
15.
Clinical characterization of long-term multiple sclerosis (COLuMbus) patients in Argentina: A cross-sectional non-interventional study.
Mult Scler Relat Disord
; 83: 105421, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244525
16.
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings.
J Neurol
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630312
17.
Serological response to SARS-CoV-2 vaccines in patients with multiple sclerosis in Argentina.
Medicina (B Aires)
; 83(3): 358-365, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37379532
18.
Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry.
Mult Scler J Exp Transl Clin
; 9(4): 20552173231205444, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37854639
19.
Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina.
Mult Scler Relat Disord
; 79: 104935, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37634468
20.
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies.
Mult Scler J Exp Transl Clin
; 9(1): 20552173231154712, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36846108